Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02322528 · ClinicalTrials.gov registry record · NA
Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02322528 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 10 participants.
The verdict
NCT02322528, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of an anti-inflammatory drug (Lotemax®) on the surface of the eye and tear film (a film that coats the eye which is made up of oil and water).
Interventions
- DRUG Administration of Lotemax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02322528
The ClinicalTrials.gov registry entry for NCT02322528 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Administration of Lotemax is the first listed.
NCT02322528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02322528 about?
NCT02322528 is a clinical study titled "Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax". The purpose of this study is to evaluate the effects of an anti-inflammatory drug (Lotemax®) on the surface of the eye and tear film (a film that coats the eye which is made up of oil and water).
What is the current status of trial NCT02322528?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-04. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02322528?
The interventions under investigation include: Administration of Lotemax (DRUG).
Who is sponsoring clinical trial NCT02322528?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.